Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CAPECITABINE Cause Therapy partial responder? 275 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 275 reports of Therapy partial responder have been filed in association with CAPECITABINE (Capecitabine). This represents 0.4% of all adverse event reports for CAPECITABINE.

275
Reports of Therapy partial responder with CAPECITABINE
0.4%
of all CAPECITABINE reports
48
Deaths
29
Hospitalizations

How Dangerous Is Therapy partial responder From CAPECITABINE?

Of the 275 reports, 48 (17.5%) resulted in death, 29 (10.5%) required hospitalization, and 11 (4.0%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CAPECITABINE. However, 275 reports have been filed with the FAERS database.

What Other Side Effects Does CAPECITABINE Cause?

Diarrhoea (9,277) Nausea (6,248) Palmar-plantar erythrodysaesthesia syndrome (5,294) Fatigue (5,018) Death (4,422) Vomiting (4,111) Disease progression (3,808) Off label use (3,193) Malignant neoplasm progression (2,425) Asthenia (2,352)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which CAPECITABINE Alternatives Have Lower Therapy partial responder Risk?

CAPECITABINE vs CAPIVASERTIB CAPECITABINE vs CAPLACIZUMAB CAPECITABINE vs CAPLACIZUMAB-YHDP CAPECITABINE vs CAPMATINIB CAPECITABINE vs CAPREOMYCIN

Related Pages

CAPECITABINE Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder CAPECITABINE Demographics